Gilead Sciences (GILD) Operating Margin (2009 - 2026)
Gilead Sciences (GILD) recorded Operating Margin of -133.21% in Q2 2026, down 168.14 percentage points from 34.93% a year earlier and down 170.36 percentage points from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Operating Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Gilead Sciences' Operating Margin came in at -8.20% as of Jun 30, 2026, down 36.09 percentage points year-over-year; for FY2025, it came in at 34.04%, up 28.26 percentage points from FY2024.
- Annual Operating Margin has a five-year change of +17.55 percentage points (FY2020 to FY2025).
- Across earlier years, Operating Margin came in at 5.78% in FY2024 (-22.27 pp), 28.05% in FY2023 (+1.18 pp), 26.87% in FY2022 (-9.45 pp) and 36.32% in FY2021 (+19.83 pp).
- The Q2 2026 figure is the lowest quarterly Operating Margin in data going back to Q1 2009.
- On a year-over-year basis, Operating Margin rose in four of the last eight quarters, with an average year-over-year change of -7.68 percentage points.
- Peak year-over-year performance for Operating Margin in the last five years was a gain of 98.20 percentage points in Q1 2025, against a drop of 168.14 percentage points in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 37.16% (Q1 2026), 25.03% (Q4 2025) and 42.82% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 2.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -133.21% |
| Mar 31, 2026 | 37.16% |
| Dec 31, 2025 | 25.03% |
| Sep 30, 2025 | 42.82% |
| Jun 30, 2025 | 34.93% |
| Mar 31, 2025 | 33.55% |
| Dec 31, 2024 | 32.40% |
| Sep 30, 2024 | 11.77% |
| Jun 30, 2024 | 38.02% |
| Mar 31, 2024 | -64.64% |
| Dec 31, 2023 | 22.66% |
| Sep 30, 2023 | 37.20% |
| Jun 30, 2023 | 25.23% |
| Mar 31, 2023 | 26.84% |
| Dec 31, 2022 | 30.68% |
| Sep 30, 2022 | 40.29% |
| Jun 30, 2022 | 32.41% |
| Mar 31, 2022 | 2.99% |
| Dec 31, 2021 | 12.98% |
| Sep 30, 2021 | 51.77% |
API Access
Gilead Sciences Operating Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-margin&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-margin", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-margin&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();